Li Yongjun, Gong Zipeng, Cao Xu, Wang Yonglin, Wang Aimin, Zheng Lin, Huang Yong, Lan Yanyu
School of Pharmacy, Guiyang Medical University, No. 9, Beijing Road, Yunyan District, Guiyang, 550004, People's Republic of China.
Engineering Research Center for the Development and Application of Ethnic Medicine and TCM, Ministry of Education, No. 9, Beijing Road, Yunyan District, Guiyang, 550004, People's Republic of China.
Eur J Drug Metab Pharmacokinet. 2016 Oct;41(5):595-603. doi: 10.1007/s13318-015-0282-5.
The bark of Eucommia ulmoides is a well-known Chinese herbal medicine that is used to regulate blood pressure and reduce blood sugar and fats, as well as an antioxidant and antimicrobial agent. Here we describe the development of a sensitive ultrahigh performance liquid chromatography-tandem mass spectrum method for the simultaneous determination of five major active ingredients of E. ulmoides bark extract, namely, geniposidic acid (GA), protocatechuic acid (PCA), chlorogenic acid (CA), (+)-pinoresinol di-O-β-D-glucopyranoside (PDG) and (+)-pinoresinol 4'-O-β-D-glucopyranoside (PG), in rat plasma. The preliminary steps in the plasma analysis were the addition of an internal standard and acidification (0.1 % formic acid), followed by protein precipitation with methanol. Separation of the active ingredients was performed on an ACQUITY UPLC® BEH C18 column (2.1 × 50 mm; internal diameter 1.7 µm) at a flow rate of 0.35 mL/min, with acetonitrile/water containing 0.1 % formic acid as the mobile phase. Detection was performed on a triple quadrupole tandem mass spectrometer via electrospray ionization source with positive and negative ionization modes. All calibration curves showed good linearity (r ≥ 0.997) over the concentration range with the low limit of quantification between 4.45 and 54.9 ng/mL. Precision was evaluated by intra- and inter-day assays, and the percentages of the relative standard deviation were all within 15 %. Extraction efficiency and matrix effect were 84.3-102.4 % and 98.1-112.2 %, respectively. The validated method was successfully applied to the pharmacokinetic study in rats after oral administration of E. ulmoides extract. The results indicate that the pharmacokinetic properties of GA differ from those of PCA, CA, PDG and PG, respectively.
杜仲树皮是一种著名的中药材,用于调节血压、降低血糖和血脂,还具有抗氧化和抗菌作用。在此,我们描述了一种灵敏的超高效液相色谱 - 串联质谱法的开发,用于同时测定大鼠血浆中杜仲树皮提取物的五种主要活性成分,即京尼平苷酸(GA)、原儿茶酸(PCA)、绿原酸(CA)、(+) - 松脂醇二 - O - β - D - 吡喃葡萄糖苷(PDG)和(+) - 松脂醇4'-O - β - D - 吡喃葡萄糖苷(PG)。血浆分析的初步步骤是加入内标并酸化(0.1%甲酸),然后用甲醇进行蛋白沉淀。活性成分在ACQUITY UPLC® BEH C18柱(2.1×50 mm;内径1.7 µm)上进行分离,流速为0.35 mL/min,以含0.1%甲酸的乙腈/水为流动相。在三重四极杆串联质谱仪上通过电喷雾电离源以正离子和负离子模式进行检测。所有校准曲线在浓度范围内均显示出良好的线性(r≥0.997),定量下限在4.45至54.9 ng/mL之间精度通过日内和日间测定进行评估,相对标准偏差的百分比均在15%以内。提取效率和基质效应分别为84.3 - 102.4%和98.1 - 112.2%。该验证方法成功应用于大鼠口服杜仲提取物后的药代动力学研究。结果表明,GA的药代动力学性质分别与PCA、CA、PDG和PG的药代动力学性质不同。